The blue-chip Swiss Market Index slipped back into the red on Friday, closing 1.15% lower, as investors digested the latest corporate updates amid a quiet day of local economic news.
Nestlé (NESN.SW) is assessing the situation and its options after Russia placed the Swiss consumer goods giant's business in the country under temporary external administration, as it took note of the Russian government's decision that was recently announced in a presidential decree.
"Nestlé is committed to taking all necessary steps to protect its rights and ensure continuity of business operations in the interests of all stakeholders, particularly its employees," the company said in a statement. The stock shed 2.63% at the end of the trading day.
Sandoz Group (SDZ.SW) signed an agreement with biopharmaceuticals company mAbxience to work together on a biosimilar of Hemlibra, or emicizumab, a treatment for patients with genetic bleeding disorder hemophilia A. Under the deal, the Swiss drugmaker will gain exclusive global commercialization rights for the proposed biosimilar, excluding Argentina, Uruguay and Paraguay, while mAbxience will be responsible for development and manufacturing.
Meanwhile, drugmaker Roche (RO.SW) secured a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use for the approval of Ocrevus intravenous infusion to treat pediatric patients aged 10 and above with relapsing forms of multiple sclerosis.
At closing, Sandoz's shares were up 1.09%, while those of Roche were 1.03% in the red.
In other news, ING Bank raised its economic growth forecast for Switzerland, citing stronger-than-expected performance so far. "We have raised our forecast for GDP growth to an average of 1.9% in 2026, while we expect growth of 1.6% in 2027. The stronger outlook reflects the solid performance recorded in the first half of the year, somewhat more favourable international demand and the recent slight weakening of the Swiss franc. Domestic demand should also continue to expand, supported by private consumption and stronger capacity utilisation."
Elsewhere, Switzerland's Federal Council adopted the 2026 Security Policy Strategy aimed at bolstering the country's defense capabilities amid an "increasingly unstable and volatile" global security situation. The council also decided that the Air Passenger Data Act will come into force on Nov. 1, 2026, with Switzerland set to use air passenger data to fight terrorism and serious crime beginning February 2027.